Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kazutaka Otsuji
Observed names:
K Otsuji,
K. Otsuji,
Otsuji Kazutaka,
Otsuji, Kazutaka
Institution:
Japanese Foundation For Cancer Research
Observed institutions:
University of Tokyo Hospital,
JR Tokyo General Hospital,
Japanese Foundation For Cancer Research,
The University of Tokyo
ORCID:
0000-0002-5688-5536
Observed ORCID:
0000-0002-5688-5536
OpenAlex ID:
A5072029001
Works
19
Awards
2
A case of primary breast angiosarcoma with multiple discontinuous small lesions
2019
·
Asako Sasahara
, Masahiko Tanabe
, et al.
·
Surgical Case Reports
·
42
PDF
Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin
2023
·
Sumito Saeki
, Kohei Kumegawa
, et al.
·
Breast Cancer Research
·
37
PDF
Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients
2016
·
Kazutaka Otsuji
, Takeshi Sasaki
, et al.
·
Breast Cancer Research and Treatment
·
32
Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growth
2017
·
H J Nakaoka
, Z Tanei
, et al.
·
Oncogenesis
·
30
PDF
Serial single-cell RNA sequencing unveils drug resistance and metastatic traits in stage IV breast cancer
2024
·
Kazutaka Otsuji
, Yoko Takahashi
, et al.
·
npj Precision Oncology
·
25
PDF
Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations
2020
·
Kazutaka Otsuji
, Takeshi Sasaki
, et al.
·
British Journal of Cancer
·
12
PDF
Axillary adipose tissue–derived lymphatic endothelial cells exhibit distinct transcriptomic signatures reflecting lymphatic invasion status in breast cancer
2025
·
Asumi Iesato
, Jun Suzuka
, et al.
·
Breast Cancer Research
·
4
PDF
Exploring Predictive Risk Factors of Infusion Reactions with First Pertuzumab Administration in HER2-positive Breast Cancer Patients: A Single Institution Experience
2023
·
Kazutaka Otsuji
, Masahiko Tanabe
, et al.
·
JMA Journal
·
4
Quantitative assessment of HER2 gene amplification of breast cancer using droplet digital PCR
2021
·
Kazutaka Otsuji
, Takeshi Sasaki
, et al.
·
Pathology International
·
4
PDF
Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients
2017
·
K. Otsuji
, T. Sasaki
, et al.
·
Annals of Oncology
·
1
Abstract 1210: Integrated spatial and single-cell profiling uncovers a pre-existing, treatment-resistant subclone that drives early local relapse in luminal breast cancer.
2026
·
Kazutaka Otsuji
, Tomo Osako
, et al.
·
Cancer Research
Abstract 711: Single-cell and spatial profiling identifies tumor features and actionable surface targets in primary breast angiosarcoma.
2026
·
Asumi Iesato
, Masashi Akiya
, et al.
·
Cancer Research
Characterizing heterogeneous cis-regulatory elements in gene regulatory programs associated with breast cancer
2025
·
Chisa Hori
, Kohei Kumegawa
, et al.
·
Genome Medicine
PDF
Treatment for hormone-receptor-positive advanced breast cancer
2020
·
Kotoe Nishioka
, Yusuke Suzuki
, et al.
·
日本乳癌学会学術総会プログラム・抄録集
Assessment of HER2 Expression in Breast Cancer Using Fluorescence-Emitting Phosphor-Integrated Dot Nanoparticles
2018
·
Otsuji Kazutaka
, Sasaki Takeshi
, et al.
·
International Journal of Oncology Research
PDF
A Surgical Case of Papillary Thyroid Carcinoma with Extrathyroidal Adenomatous Goiter
2015
·
Kazutaka Otsuji
, Yoko Omi
, et al.
·
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
PDF
Show more works
View as search
Works count:
19
Citation count:
191
H-index:
6
I10-index:
6
Year
Topic
Type